Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Assess the Effectiveness and Safety of Lenacapavir for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PURPOSE 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04925752
Recruitment Status : Active, not recruiting
First Posted : June 14, 2021
Last Update Posted : May 11, 2022
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2024
Estimated Study Completion Date : April 2027